Boston Scientific ROA 2006-2018 | BSX

Current and historical return on assets (ROA) values for Boston Scientific (BSX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Boston Scientific ROA for the three months ending September 30, 2018 was 10.16%.
Boston Scientific ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.67B $20.38B 3.43%
2018-06-30 $0.52B $19.62B 2.72%
2018-03-31 $0.11B $19.20B 0.60%
2017-12-31 $0.10B $19.04B 0.56%
2017-09-30 $0.84B $18.64B 4.62%
2017-06-30 $0.79B $18.38B 4.37%
2017-03-31 $0.44B $17.94B 2.43%
2016-12-31 $0.35B $18.10B 1.95%
2016-09-30 $0.08B $17.70B 0.45%
2016-06-30 $-0.35B $17.84B -1.92%
2016-03-31 $-0.04B $17.72B -0.20%
2015-12-31 $-0.24B $18.13B -1.37%
2015-09-30 $-0.40B $18.22B -2.30%
2015-06-30 $-0.16B $17.12B -0.92%
2015-03-31 $-0.25B $16.47B -1.52%
2014-12-31 $-0.12B $17.02B -0.72%
2014-09-30 $0.29B $16.72B 1.74%
2014-06-30 $0.24B $16.48B 1.45%
2014-03-31 $0.37B $16.34B 2.19%
2013-12-31 $-0.12B $16.57B -0.72%
2013-09-30 $-0.17B $16.92B -0.99%
2013-06-30 $-0.83B $17.00B -4.88%
2013-03-31 $-4.54B $16.76B -26.43%
2012-12-31 $-4.07B $17.15B -22.27%
2012-09-30 $-4.02B $16.90B -20.84%
2012-06-30 $-3.22B $17.82B -15.73%
2012-03-31 $0.51B $21.19B 2.38%
2011-12-31 $0.44B $21.29B 2.04%
2011-09-30 $0.57B $21.50B 2.61%
2011-06-30 $0.62B $21.56B 2.80%
2011-03-31 $0.57B $22.07B 2.54%
2010-12-31 $-1.07B $22.13B -4.71%
2010-09-30 $-2.38B $22.49B -10.17%
2010-06-30 $-2.66B $23.02B -10.94%
2010-03-31 $-2.60B $22.85B -10.36%
2009-12-31 $-1.03B $25.18B -3.95%
2009-09-30 $-2.33B $26.23B -8.82%
2009-06-30 $-2.31B $26.19B -8.46%
2009-03-31 $-2.37B $26.11B -8.40%
2008-12-31 $-2.04B $27.14B -6.95%
2008-09-30 $-0.11B $29.83B -0.37%
2008-06-30 $-0.31B $29.90B -1.01%
2008-03-31 $-0.29B $30.35B -0.94%
2007-12-31 $-0.50B $31.20B -1.59%
2007-09-30 $0.24B $31.33B 0.77%
2007-06-30 $0.59B $31.27B 1.90%
2007-03-31 $-3.79B $31.07B -12.29%
2006-12-31 $-3.58B $30.88B -14.12%
2006-09-30 $-3.52B $30.75B -17.90%
2006-06-30 $-3.87B $30.61B -27.61%
2006-03-31 $0.60B $9.11B 7.20%
2005-12-31 $0.63B $8.20B 7.81%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.097B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.569B 18.92
Abbott Laboratories (ABT) United States $122.855B 24.89
Stryker (SYK) United States $63.182B 23.82
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $22.421B 14.54
Smith & Nephew SNATS (SNN) United Kingdom $16.589B 0.00
ResMed (RMD) United States $15.674B 29.89
Perrigo (PRGO) Ireland $8.142B 12.36
Bio-Rad Laboratories (BIO) United States $7.677B 49.09
Canopy Growth (CGC) Canada $7.290B 0.00
Hill-Rom Holdings (HRC) United States $6.241B 19.53
Aurora Cannabis (ACB) Canada $5.730B 30.26
Haemonetics (HAE) United States $5.332B 46.90
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.752B 26.48
Hutchison China MediTech (HCM) China $4.204B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.765B 0.00
Neogen (NEOG) United States $3.198B 48.43
Agios Pharmaceuticals (AGIO) United States $3.093B 0.00
NuVasive (NUVA) United States $2.886B 26.85
National Vision Holdings (EYE) United States $2.497B 48.30
NxStage Medical (NXTM) United States $1.925B 0.00
Quidel (QDEL) United States $1.917B 24.99
Phibro Animal Health (PAHC) United States $1.327B 18.78
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.204B 0.00
Cardiovascular Systems (CSII) United States $0.991B 1428.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.886B 22.96
Meridian Bioscience (VIVO) United States $0.778B 24.80
Surmodics (SRDX) United States $0.766B 116.65
OraSure Technologies (OSUR) United States $0.752B 42.35
Cerus (CERS) United States $0.726B 0.00
MacroGenics (MGNX) United States $0.693B 0.00
Omeros (OMER) United States $0.687B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.00
Lantheus Holdings (LNTH) United States $0.652B 20.17
NanoString Technologies (NSTG) United States $0.527B 0.00
LeMaitre Vascular (LMAT) United States $0.502B 24.65
Owens & Minor (OMI) United States $0.433B 4.90
Quanterix (QTRX) United States $0.433B 0.00
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.385B 0.00
Evolus (EOLS) United States $0.375B 0.00
VAPOTHERM INC (VAPO) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.90
Cytosorbents (CTSO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.207B 279.25
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.135B 6.77
Imprimis Pharmaceuticals (IMMY) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.079B 16.53
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.27
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.052B 0.00
Neurotrope (NTRP) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00